Archives: Agenda

In an era of rapid transformation, the Middle East’s hotel and tourism sectors are experiencing a complex and nuanced job market landscape.

Key Discussion Points:

• Detailed examination of job posting trends in Travel & Tourism
• Unprecedented shifts in the Middle East’s hospitality employment sector
• Emerging opportunities in the luxury hotel segment

Apple Prize Draw taking place in exhibition room – please ensure your cards are stamped and submitted by 1:15pm

• Changing foreign relations priorities in US
• History of the US BioSecure Act, its future, and potential impact on the Pharmaceutical Industry
• US pharma industry reliance on foreign CROs and CDMOs to advance research
• Risk assessment for companies with ongoing drug development activities with a foreign CRO/CDMO

• Sustaining community outreach and engagement through CISCRP’s Journey to Better Health Mobile Unit
• The impact on perceptions and behaviors with regards to clinical research
• Partnering with community educators, drawing attention to the need to be aware of clinical research

The evolving regulatory landscape following the Trump administration has introduced significant changes that continue to affect clinical trials. This session will explore the lasting impact of policy shifts on trial design, patient recruitment, and data transparency. Industry experts will discuss key regulatory updates, including FDA guidance changes, supply chain implications, and funding adjustments. Attendees are welcome to interact and discuss how these developments are shaping clinical research strategies and what steps organizations can take to ensure compliance and operational efficiency in this new environment.

• What is patient experience data collection and why does it matter?
• Mechanisms for patient engagement across the product development lifecycle
• Demonstrating the value of patient engagement from a variety of perspectives (i.e. biopharmaceutical, patient advocacy, regulatory, and payer)
• Understanding roles and responsibilities for patient advocacy organizations, patient opinion leaders, pharmaceutical sponsors, etc.